LX22001

· Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LX22001, covering 2024-08-20 to 2024-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of LX22001 for Injection in Healthy Subjects [Phase 1]